Ethiopia

in page functions
[French]
Ethiopia
Total population (2016) 101,852,974
Birth cohort (2016) 3,203,712
Surviving Infants (surviving to 1 year per year, 2016) 3,061,161
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 41/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 59/1000
World Bank Index, IDA (2012) 3.41
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 840

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Ethiopia

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $910,196,114 $1,046,707,614 $853,392,369
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $3,320,000 $3,320,000 $3,420,000 103%
Health system strengthening (HSS 1) $76,493,935 $76,493,935 $76,493,935 100%
Health system strengthening (HSS 2) $61,410,682 $61,410,682 $61,410,682 100%
Health system strengthening (HSS 3) $34,540,000 $80,590,000
HPV Demo (NVS) $149,399 $149,399 $148,719 100%
Immunisation services support (ISS) $23,445,320 $23,445,320 $17,813,320 76%
Injection Safety Devices (NVS) $1,127,500 $2,717,500
Injection safety support (INS) $2,696,697 $2,696,697 $2,696,697 100%
IPV (NVS) $7,825,662 $7,825,662 $3,775,838 48%
Measles SIA (NVS) $8,599,190 $8,599,190 $8,799,472 102%
Measles SIA - Operational costs (OPC) $15,263,500 $15,263,500 $15,240,788 100%
Meningitis A - campaign (NVS) $43,030,647 $43,030,647 $44,310,479 103%
Meningitis A - operational costs (OPC) $37,950,270 $37,950,270 $34,029,203 90%
Penta (NVS) $233,108,717 $282,587,217 $226,017,936 97%
Pneumo (NVS) $296,944,251 $296,944,251 $304,017,823 102%
Rotavirus (NVS) $58,133,344 $97,501,344 $49,060,476 84%
Vaccine Introduction Grant (VIG) $5,987,000 $5,987,000 $5,987,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Ethiopia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 96%
M:F sex ratio at birth (2016) 1.04
Household survey: DTP3 coverage for male (2010) 34.30%
Household survey: DTP3 coverage for female (2010) 38.80%
Household survey: Last DTP3 survey (2010) 37%
% districts achieving > 80% DTP3 coverage (2015) 74%
% districts achieving < 50% DTP3 coverage (2015) 8%
MCV WHO/UNICEF estimates (2015) 78%

Breakdown of support

Non-vaccine support Vaccine support
25% 75%
$217,261,625 $636,130,741

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Ethiopia

10 November 2016

Tanzania

Measles jab saves over 20 million young lives in 15 years, but hundreds of children still die of the disease every day

Measles outbreaks in numerous countries – caused by gaps in routine immunisation and in mass vaccination campaigns – continue to be a serious challenge.

11 October 2016

Gavi Girl Effect

Girl Effect and Gavi join forces with US$ 10 million commitment to fight cervical cancer in developing world

Without intervention the rising number of deaths from cervical cancer will exceed maternal mortality rates in developing countries.

19 September 2016

Stockpiling

On the frontline: Gavi's support to fragile states

With more than half of Gavi-supported countries officially listed as fragile states, Gavi is increasingly working on several fronts to ensure vaccines still reach people living on the frontlines of humanitarian crises.

close icon

modal window here